MST Financial has put out an initial report, with a valuation of $0.34
A really well written report spelling out the difference between CAR-T and its limitations and iNKT and what we think will be the future of Blood & Solid tumour treatments
MST Financial Initiation Report - CAR-iNKT, Next Gen Cancer Killer
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $24.82K | 239.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 263960 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 430296 | 6 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| ALA (ASX) Chart |